Hongzhou Cai
- Topics
- Bladder and Urothelial Cancer Treatments (11 papers)Epigenetics and DNA Methylation (7 papers)MicroRNA in disease regulation (5 papers)
- Partner nations
- ChinaItalyUnited States
In The Last Decade
Hongzhou Cai
43 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 610
- Cancer Research 493
- Pulmonary and Respiratory Medicine 235
- Oncology 203
- Genetics 149
Countries citing papers authored by Hongzhou Cai
This map shows the geographic impact of Hongzhou Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongzhou Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongzhou Cai more than expected).
Fields of papers citing papers by Hongzhou Cai
This network shows the impact of papers produced by Hongzhou Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongzhou Cai. The network helps show where Hongzhou Cai may publish in the future.
Co-authorship network of co-authors of Hongzhou Cai
This figure shows the co-authorship network connecting the top 25 collaborators of Hongzhou Cai. A scholar is included among the top collaborators of Hongzhou Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongzhou Cai. Hongzhou Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 9 | |
| 3 | 4 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 6 | |
| 8 | 6 | |
| 9 | 35 | |
| 10 | 13 | |
| 11 | 55 | |
| 12 | 3 | |
| 13 | 3 | |
| 14 | 137 | |
| 15 | 13 | |
| 16 | 8 | |
| 17 | 14 | |
| 18 | 2 | |
| 19 | 22 | |
| 20 | 33 |
About Hongzhou Cai
Hongzhou Cai is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 44 papers that have together received 1.0k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (11 papers), Epigenetics and DNA Methylation (7 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (493 citations), Molecular Biology (610 citations) and Oncology (203 citations). Hongzhou Cai has collaborated with scholars based in China, Italy and United States. Frequent co-authors include Ting Xu, Zicheng Xu, Xinwei Wang, Qing Zou, Changjun Yin, Qiang Cao, Chao Qin, Xiaobing Ju, Bin Yu and Pengfei Shao. Their work appears in journals such as PLoS ONE, Advanced Functional Materials and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.